These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4288409)

  • 21. Cushing's syndrome with a paradoxical response to dexamethasone.
    French FS; Macfie JA; Baggett B; Williams TF; Van Wyk JJ
    Am J Med; 1969 Oct; 47(4):619-24. PubMed ID: 4309844
    [No Abstract]   [Full Text] [Related]  

  • 22. [Paradoxical response of adrenal glands to dexamethasone in a case of adrenal carcinoma].
    Medizinische Poliklinik der Universität Würzburg
    MMW Munch Med Wochenschr; 1975 May; 117(22):955-6. PubMed ID: 168485
    [No Abstract]   [Full Text] [Related]  

  • 23. Cushing's syndrome with fluctuation due to adrenal adenoma.
    Green JR; van't Hoff W
    J Clin Endocrinol Metab; 1975 Aug; 41(2):235-40. PubMed ID: 1159041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone.
    Brown RD; Van Loon GR; Orth DN; Liddle GW
    J Clin Endocrinol Metab; 1973 Mar; 36(3):445-51. PubMed ID: 4346603
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnosis of Cushing's syndrome. The differentiation between adrenocortical hyperplasia and adrenocrotical adenoma by means of lysine-vasopressin.
    Bethge H; Bayer JM; Winkelmann W
    Acta Endocrinol (Copenh); 1969 Jan; 60(1):47-59. PubMed ID: 4308289
    [No Abstract]   [Full Text] [Related]  

  • 26. Periodic remission in Cushing's disease with paradoxical dexamethasone response: an expression of periodic hormonogenesis.
    Liberman B; Wajchenberg BL; Tambascia MA; Mesquita CH
    J Clin Endocrinol Metab; 1976 Oct; 43(4):913-8. PubMed ID: 185234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of activity of the adrenal cortex by dexamethasone in Cushing's syndrome.
    Cassidy CE; Rosenfeld PS; Bokat MA
    J Clin Endocrinol Metab; 1966 Nov; 26(11):1181-4. PubMed ID: 5924281
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on the efficiency of adrenocortical 11 beta-hydroxylation in the human subject.
    Nicolis GL; Gabrilove JL
    J Clin Endocrinol Metab; 1969 Jun; 29(6):831-6. PubMed ID: 4306479
    [No Abstract]   [Full Text] [Related]  

  • 29. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of metyrapone to inhibit 11-hydroxylation of 11-deoxycortisol during drug therapy.
    Werk EE; Thrasher K; Choi Y; Sholiton LJ
    J Clin Endocrinol Metab; 1967 Sep; 27(9):1358-60. PubMed ID: 4292251
    [No Abstract]   [Full Text] [Related]  

  • 31. Temporal rhythm in the response of urinary 17-OHCS to metopirone in Cushing's syndrome due to bilateral adrenal hyperplasia.
    Takebe K
    J Clin Endocrinol Metab; 1973 Mar; 36(3):433-8. PubMed ID: 4685385
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of o,p'-DDD on cortisol secretory pattern in Cushing's syndrome.
    Hellman L; Weitzman ED; Roffwarg H; Fukushima DK; Yoshida K; Zumoff B; Gallagher TF
    J Clin Endocrinol Metab; 1970 Aug; 31(2):227-30. PubMed ID: 4316529
    [No Abstract]   [Full Text] [Related]  

  • 33. [Functional study of the glycoactive adrenal gland in the aged patient. II. Functional tests with metopirone, dexamethasone and bacterial pyretogen].
    Lenzi S; Abate G; Bernardi P; Montini T
    Endocrinol Sci Cost; 1968 Sep; 30(1):51-68. PubMed ID: 4313389
    [No Abstract]   [Full Text] [Related]  

  • 34. Anomalous response to metyrapone in Cushing's syndrome due to adrenocortical adenoma.
    Pennington LF; Kreisberg RA; Hershman JM
    J Clin Endocrinol Metab; 1970 Jan; 30(1):125-7. PubMed ID: 4311614
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of amino-glutethimide on adrenal function in man.
    Fishman LM; Liddle GW; Island DP; Fleischer N; Küchel O
    J Clin Endocrinol Metab; 1967 Apr; 27(4):481-90. PubMed ID: 4290077
    [No Abstract]   [Full Text] [Related]  

  • 36. [On regulation of the daily rhythm of adrenal cortex hormones in corticosteroma].
    Gur'eva IG; Kertsman VI
    Probl Endokrinol Gormonoter; 1966; 12(4):3-7. PubMed ID: 4301286
    [No Abstract]   [Full Text] [Related]  

  • 37. Patterns of urinary excretion of steroids in Cushing's syndrome.
    Martin MM; Hamman BL
    J Clin Endocrinol Metab; 1966 Mar; 26(3):257-67. PubMed ID: 4286016
    [No Abstract]   [Full Text] [Related]  

  • 38. Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia.
    Findlay JC; Sheeler LR; Engeland WC; Aron DC
    J Clin Endocrinol Metab; 1993 Jan; 76(1):189-91. PubMed ID: 8380604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of single doses of dexamethasone and adrenocorticotrop hormone on serum bone markers in healthy subjects and in patients with adrenal incidentalomas and Cushing's syndrome.
    Majnik J; Szücs N; Patócs A; Tóth M; Balogh K; Varga I; Gláz E; Rácz K
    J Endocrinol Invest; 2004 Sep; 27(8):747-53. PubMed ID: 15636428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pitfalls of functional tests for the establishment of the etiology of Cushing's syndrome in childhood and adolescence.
    Rivarola MA; Mendilaharzu H; Dahl V; Heinrich JJ; Spada RP; Mora H; Bergadá C; Cullen M
    J Clin Endocrinol Metab; 1970 Sep; 31(3):254-9. PubMed ID: 4318200
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.